In Stock

10mg(30iu) 1.5ml HGH (Human Growth Hormone) cartridges



Omnitrope is a growth hormone which is created in the laboratory. It is also referred to as somatropin and it’s used for people with idiopathic/short stature, Prader-Willi syndrome, sometimes used in small amounts for gestational age and people with Turners syndrome along with other growth-related disorders.
Before using Omnitrope, it’s important to note that this drug can produce different therapeutic effects depending on the condition that one has, the age of the individual and most importantly the dosage as well. In this article, you will learn how Omnitrope should properly be used in the case of children (pediatrics) and among adults with growth-related disorders.
Children with growth failure are often caused by the secretion failure of a growth hormone (GH).The route of administration is by injection which is recommended when the diagnosis of growth failure is confirmed. Depending on the condition dosing of Omnitrope varies;
Idiopathic short stature
Pediatrics with a standard deviation score of ≤ -2.25 and shows the probability of not attaining normal range the adult height should be given Omnitrope. Somatropin should be administered up to 0.47mg per kg of body weight recommended being given per week. The administration of this dose should also be divided either over 6 or 7 days subcutaneously.
Turner Syndrome
With a division of a weekly dose over 6 or 7 days which is done subcutaneously, somatropin should be administered at a dose of 0.33 mg/kg. This dose is often recommended when there is growth failure which is associated with Turner’s syndrome.
Prader-Willi Syndrome
A weekly dose of 0.24mg/kg is recommended for administration. The weekly dose which is done subcutaneously is divided over 6 or 7 days.
Before administration of this drug, pediatric patients who have growth failure as a result of Prader- Willi Syndrome should go through genetic testing so that the physician can give you advice on contraindications which can be associated with Omnitrope.
Pediatric Growth Hormone Deficiency
Children diagnosed with growth hormone deficiency (GH) should be given a dose which is 0.16 to 0.24 mg/kg and be administered subcutaneously to produce the desired therapeutic effects.
Small for Gestational age (SGA)
Usually, pediatrics with a small gestational age disorder are recommended to be given 0.48mg/kg of body weight a week. This weekly dose should be administered subcutaneously and be divided over a period of 6 to 7days.
For Adults the dose for somatropin in adults with growth disorders vary. It is recommended that the dosage at the start of the therapy should not be more than 0.04mg/kg per week. This dose can be increased with an interval of 4to 8 weeks but the dose should not exceed 0.08 per week. Note that this does is administered subcutaneously.
Before you go into the market to have somatropin be informed of convenient pens; that ensures that liquid cartridge stays for 28days after the first injection, flexibility of the dosage to fit the needs of an individual and ensuring that ones the cartridge is inserted the pen must be primed for use. Just a REMINDER, each Omnitrope comes with 1.14 mL vial bacteriostatic water which can be preserved with benzyl alcohol mix in a solution before injection.

Additional information


1Pen, 5 Pens, 10 Pens, 20 Pens


There are no reviews yet.

Be the first to review “Buy Omnitrope Pen HGH 10mg 30IU Online Somatropina Sandoz Injectable For Sale UK Europe USA Thailand”

Your email address will not be published. Required fields are marked *